Key Points
Death toll of 2,325 surpasses Congo's previous worst outbreak from 2018-2020.
Outbreak reached 2,000 deaths in less than three months, three times faster than 2014-2016 West Africa crisis.
Bundibugyo strain has no approved vaccines or treatments and spreads across six provinces.
Case fatality rate of 46 percent driven by late detection and weak health infrastructure, not virus lethality.
The Ebola outbreak in the Democratic Republic of Congo has killed 2,325 people, surpassing the country’s deadliest previous outbreak from 2018-2020. With 4,945 confirmed cases and a case fatality rate of 46 percent, the outbreak declared on May 15 is now the second deadliest in global history, behind only West Africa’s 2014-2016 outbreak. The Bundibugyo strain has no approved vaccines or treatments, and weak health infrastructure is hampering response efforts.
Death toll accelerates faster than any previous outbreak
Congo’s current outbreak reached 2,000 deaths in less than three months. By comparison, West Africa’s 2014-2016 outbreak took nearly five months to hit 1,000 deaths. The case fatality rate has jumped from about 20 percent in early June to 46 percent, meaning nearly one in every two confirmed cases is now fatal, according to government data.
Bundibugyo strain spreads across six provinces
The outbreak has now spread to six of Congo’s 26 provinces, mainly along the north-eastern border. More than 3,400 cases have been recorded in Ituri province, where the outbreak began. Jean Kaseya, director general of Africa CDC, confirmed on August 13 that a death was recorded in Bas-Uele province after a man travelled from Haut-Uele. Uganda has reported 20 cases, all in Kampala, with the last case on June 21.
Health system collapse and misinformation fuel spread
Weak health infrastructure, community resistance, and instability are hindering case identification and response. Health workers at the Nizi treatment centre in Ituri province went on strike on Thursday after not being paid for three months. Misinformation claiming Ebola is not real, combined with threats from rebel groups, has compounded the crisis.
Rising case fatality ratio reflects late detection, not deadlier virus
Thomas Parisch, a public health specialist with Medecins Sans Frontieres, said the rising case fatality ratio does not mean the virus has become more lethal. Instead, many cases are detected very late, when treatment is less likely to succeed, or only after patients die in the community. Experimental vaccines and therapies are being evaluated, while authorities assess whether existing Ebola treatments could work against the Bundibugyo strain.
Final Thoughts
Congo’s Ebola outbreak is now the second deadliest in global history, with deaths mounting three times faster than the 2014-2016 West Africa crisis. Without approved vaccines or treatments and amid health worker strikes and community mistrust, the trajectory remains dire.
FAQs
2,325 people have died out of 4,945 confirmed cases as of August 16, 2026, surpassing the country’s previous worst outbreak from 2018-2020.
Many cases are detected very late when treatment is less likely to succeed, or only after patients die in the community, not because the virus is more lethal.
No approved vaccines or treatments exist for the Bundibugyo strain. Experimental vaccines and therapies are being evaluated.
Six of Congo’s 26 provinces have been affected, mainly along the north-eastern border, with Ituri province accounting for more than 3,400 cases.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
About Author

Huzaifa Zahoor
Co FounderHuzaifa Zahoor is the engineer who built Meyka. He has spent years writing Python, training AI models, and building data pipelines specifically for financial markets. His technical articles have reached over 30,000 readers on Medium, so he knows how to make complex things easy to follow. If this article touches on how the tools work, he is the person who actually built them.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)